Trientine Hydrochloride Capsule
Product Images NDC 68475-200

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Trientine Hydrochloride (NDC 68475-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C3138afe B97a 420e 9129 E09d4622f5d8 01

Each capsule of this medication contains 250 mg of Trientine Hydrochloride, a medication used for Wilson's disease, a genetic disorder that causes the body to retain too much copper. The usual dosage and other important information can be found in the accompanying package insert. This medication should be stored in a tightly closed, refrigerated container and is not child-resistant. The package is intended for dispensing and contains 100 capsules. This medication was manufactured for Navinta LLC in Ewing, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.